Compare CWK & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CWK | AXGN |
|---|---|---|
| Founded | 1784 | N/A |
| Country | United States | United States |
| Employees | 53000 | N/A |
| Industry | Real Estate | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.6B |
| IPO Year | 2018 | 2013 |
| Metric | CWK | AXGN |
|---|---|---|
| Price | $13.78 | $54.39 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 11 |
| Target Price | $16.45 | ★ $59.09 |
| AVG Volume (30 Days) | ★ 3.5M | 1.7M |
| Earning Date | 11-04-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | ★ $10,288,200,000.00 | $225,208,000.00 |
| Revenue This Year | $8.49 | $28.93 |
| Revenue Next Year | $6.13 | $28.36 |
| P/E Ratio | $35.73 | ★ N/A |
| Revenue Growth | 8.91 | ★ 20.21 |
| 52 Week Low | $10.88 | $23.00 |
| 52 Week High | $17.40 | $52.91 |
| Indicator | CWK | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 55.70 | 74.52 |
| Support Level | $13.56 | $39.18 |
| Resistance Level | $14.32 | N/A |
| Average True Range (ATR) | 0.69 | 2.51 |
| MACD | 0.14 | 1.05 |
| Stochastic Oscillator | 58.12 | 97.94 |
Cushman & Wakefield is a global commercial real estate services firm providing leasing, capital markets, property management, and project management to occupiers, owners, and investors across property types including office, industrial, retail, and data centers. The firm traces its roots back to 1917, when it was founded by brothers-in-law J. Clydesdale Cushman and Bernard Wakefield, and grew into its current form largely through a transformative 2015 merger with DTZ, a firm backed by TPG, PAG Asia Capital, and Ontario Teachers' Pension Plan. As of early 2026, the firm operates across roughly 400 offices in 60 countries with approximately 53,000 people.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.